首页> 外文OA文献 >Combination of serum CA19-9 and CA125 levels and contrast-enhanced ultrasound parametric data facilitates to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer

【2h】

Combination of serum CA19-9 and CA125 levels and contrast-enhanced ultrasound parametric data facilitates to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer

机译：血清CA19-9和CA125水平和对比度增强的超声参数数据的组合有助于区分卵巢恶性上皮癌的卵巢浆液癌

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Wei Zhang; Liying Wang; Zhongqiu Xin;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age [J] . Kondalsamy-ChennakesavanS., HackethalA., BowtellD., Gynecologic Oncology: An International Journal . 2013,第3期

机译：结合肿瘤标志物HE4，CA125和CEA以及患者年龄，将1期上皮性卵巢癌与良性卵巢肿瘤区分开
2. Reduction of CA125 Levels During Neoadjuvant Chemotherapy Can Predict Cytoreduction to No Visible Residual Disease in Patients with Advanced Epithelial Ovarian Cancer, Primary Carcinoma of Fallopian tube and Peritoneal Carcinoma [J] . Jing Zeng, Jie Yin, Xiao Song, Journal of Cancer . 2016,第15期

机译：新辅助化疗过程中CA125水平的降低可预测晚期上皮性卵巢癌，输卵管原发癌和腹膜癌患者的细胞减少至无可见残留疾病
3. Reduction of CA125 Levels During Neoadjuvant Chemotherapy Can Predict Cytoreduction to No Visible Residual Disease in Patients with Advanced Epithelial Ovarian Cancer, Primary Carcinoma of Fallopian tube and Peritoneal Carcinoma [J] . Jing Zeng, Jie Yin, Xiao Song, Journal of Cancer . 2016,第15期

机译：新辅助化疗过程中CA125水平的降低可预测晚期上皮性卵巢癌，输卵管原发癌和腹膜癌患者的细胞减少至无可见残留疾病
4. Effect of feature extraction and feature selection on expression data from epithelial ovarian cancer [C] . Turkeli Y., Ercil A., Sezerman O.U. Engineering in Medicine and Biology Society, 2003. Proceedings of the 25th Annual International Conference of the IEEE . 2003

机译：特征提取和特征选择对上皮性卵巢癌表达数据的影响
5. Colony-Stimulating Factor-1 Receptor Inhibition Reverses the Vascular Leakage that Causes Malignant Ascites in Late-Stage Epithelial Ovarian Cancer [D] . Moughon, Diana Louise 2015

机译：集落刺激因子-1受体抑制逆转导致晚期上皮性卵巢癌的恶性腹水的血管渗漏。
6. Combination of serum CA19-9 and CA125 levels and contrast-enhanced ultrasound parametric data facilitates to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer [O] . Wei Zhang, Liying Wang, Zhongqiu Xin -1

机译：血清CA19-9和CA125水平以及对比增强的超声参数数据的结合有助于区分卵巢浆液性癌和卵巢恶性上皮癌
7. Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas [O] . Ji Hui Choi, Geum Seon Sohn, Doo Byung Chay, 2018

机译：术前血清癌抗原125和癌胚抗原比可以改善粘液卵巢癌和其他上皮卵巢癌之间的分化
8. Pathogenesis of Ovarian Serous Carcinoma as the Basis for Immunologic Directed Diagnosis and Treatment. Project 3 - Development of Antigen-Specific Cancer Vaccines for the Control of Ovarian Cancer [R] . Kurman, R. J. , Wu, T. C. 2003

机译：卵巢浆液性癌的发病机制作为免疫定向诊断和治疗的基础。项目3-开发用于控制卵巢癌的抗原特异性癌症疫苗

Combination of serum CA19-9 and CA125 levels and contrast-enhanced ultrasound parametric data facilitates to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer

著录项

引文网络

相似文献

相关主题

期刊订阅